Gastric Cancer Maximum Tumour Diameter Reduction Rate at CT Examination as a Radiological Index for Predicting Histopathological Regression after Neoadjuvant Treatment: A Multicentre GIRCG Study

<table class="table-group" id="tab2"><tr><td><table class="table"><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr class="thead"><td class="align_left">GIRCG center</td><td class="align_center">Tomograph</td><td class="align_center">Layers</td><td class="align_center">Patients (number)</td></tr><tr><td class="thead-hr" colspan="4"><hr/></td></tr><tr><td class="align_left">Siena</td><td class="align_center">VCT, GE Healthcare</td><td class="align_center">64</td><td class="align_center">32</td></tr><tr><td class="align_left">Forlì</td><td class="align_center">LightSpeed Pro, GE Healthcare</td><td class="align_center">16</td><td class="align_center">19</td></tr><tr><td class="align_left">Montevarchi</td><td class="align_center">LightSpeed Pro, GE Healthcare</td><td class="align_center">32</td><td class="align_center">18</td></tr><tr><td class="align_left">Brescia</td><td class="align_center">Siemens Somatom Definition Flash DE</td><td class="align_center">128</td><td class="align_center">9</td></tr><tr><td class="align_left">Verona</td><td class="align_center">LightSpeed, GE HealthCare</td><td class="align_center">64</td><td class="align_center">8</td></tr><tr class="table-tr"><td colspan="4"><hr class="tbody-hr"/></td></tr></table></td></tr></table>

<div>List of tomographs adopted in the study.</div>

Gastroenterology Research and Practice

tab2

Table 2

Table 2: Gastric Cancer Maximum Tumour Diameter Reduction Rate at CT Examination as a Radiological Index for Predicting Histopathological Regression after Neoadjuvant Treatment: A Multicentre GIRCG Study 

Table 2 | Gastric Cancer Maximum Tumour Diameter Reduction Rate at CT Examination as a Radiological Index for Predicting Histopathological Regression after Neoadjuvant Treatment: A Multicentre GIRCG Study 